Table 2.
Univariate analyses for PFS and OS in 122 MDS patients in relation to prognostic parameters.
| PFS | OS | |||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P | HR | 95%CI | P | |
| P-LCR (<36.7 VS ≥36.7) | 0.263 | 0.087-0.794 | 0.018 | 0.578 | 0.363-0.919 | 0.020 |
| Sex | 0.460 | 0.206-1.030 | 0.059 | 1.046 | 0.662-1.653 | 0.864 |
| Age (year) | 0.998 | 0.966-1.031 | 0.898 | 1.015 | 0.996-1.033 | 0.116 |
| bone marrow blast (%) | 1.001 | 0.914-1.096 | 0.986 | 1.083 | 1.042-1.126 | P<0.001 |
| WBC (×109/L) | 1.063 | 0.900-1.256 | 0.472 | 1.051 | 0.955-1.157 | 0.309 |
| ANC (×109/L) | 1.072 | 0.856-1.342 | 0.547 | 1.023- | 0.893-1.173- | 0.742 |
| Hb (g/L) | 1.014 | 0.997-1.032 | 0.116 | 1.007 | 0.997-1.017 | 0.148 |
| PLT (×109/L) | 0.993 | 0.987-1.000 | 0.057 | 0.997 | 0.994-0.999 | 0.018 |
| IPSS scores | 1.319 | 0.781-2.228 | 0.300 | 1.530 | 1.160-2.018 | 0.003 |
CI, confidence interval; HR, hazard ratio; PLT, platelet count; PFS, progression-free survival; OS, overall survival.